Daniel C. Rowe
Impact in
- Immunology top 0.2%
- Immune Response and Inflammation
- interferon and immune responses
- Immunotherapy and Immune Responses
- Aquaculture disease management and microbiota
- Clinical Biochemistry top 0.5%
- Advanced Glycation End Products research
Papers in
-
- Immune Response and Inflammation 4
- interferon and immune responses 2
-
- Escherichia coli research studies 1
- Co-authors
- Katherine A. Fitzgerald (6 shared papers)Douglas Taylor Golenbock (6 shared papers)Anthony J. Coyle (2 shared papers)Eicke Latz (3 shared papers)Sarah M. McWhirter (2 shared papers)Tom Maniatis (2 shared papers)Sha-Mei Liao (1 shared paper)Gary P. Sims (3 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (3 papers)Nature Immunology (1 paper)Annual Review of Immunology (1 paper)Microbes and Infection (1 paper)Cellular Microbiology (1 paper)
- Partner nations
- United StatesIrelandUnited Kingdom
In The Last Decade
Daniel C. Rowe
11 papers receiving 5.9k citations
Daniel C. Rowe's Hit Papers
Peers
Comparison fields: 5 of 93
- Immunology 3.6k
- Clinical Biochemistry 402
- Cancer Research 341
- Neurology 150
- Endocrinology 62
Countries citing papers authored by Daniel C. Rowe
This map shows the geographic impact of Daniel C. Rowe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel C. Rowe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel C. Rowe more than expected).
Fields of papers citing papers by Daniel C. Rowe
This network shows the impact of papers produced by Daniel C. Rowe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel C. Rowe. The network helps show where Daniel C. Rowe may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel C. Rowe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | IKKε and TBK1 are essential components of the IRF3 signaling pathway Hit paper breakdown → | 2003 | 2326 |
| 2 | HMGB1 and RAGE in Inflammation and Cancer Hit paper breakdown → | 2010 | 1237 |
| 3 | LPS-TLR4 Signaling to IRF-3/7 and NF-κB Involves the Toll Adapters TRAM and TRIF Hit paper breakdown → | 2003 | 1017 |
| 4 | 2003 | 477 | |
| 5 | 2004 | 277 | |
| 6 | 2006 | 229 | |
| 7 | 2010 | 119 | |
| 8 | 2006 | 113 | |
| 9 | 2015 | 102 | |
| 10 | 2006 | 41 | |
| 11 | 2013 | 22 |
About Daniel C. Rowe
Daniel C. Rowe is a scholar working on Immunology, Endocrinology, Clinical Biochemistry, Radiology, Nuclear Medicine and Imaging and Epidemiology, having authored 11 papers that have together received 6k indexed citations. Recurring topics across this work include Immune Response and Inflammation (4 papers), interferon and immune responses (2 papers), Respiratory viral infections research (1 paper), Escherichia coli research studies (1 paper), S100 Proteins and Annexins (1 paper), Advanced Glycation End Products research (1 paper) and Monoclonal and Polyclonal Antibodies Research (1 paper). The work is most often cited by research in Immunology (3.6k citations), Clinical Biochemistry (402 citations), Cancer Research (341 citations), Neurology (150 citations) and Endocrinology (62 citations). Daniel C. Rowe has collaborated with scholars based in United States, Ireland and United Kingdom. Frequent co-authors include Katherine A. Fitzgerald, Douglas Taylor Golenbock, Anthony J. Coyle, Eicke Latz, Sarah M. McWhirter, Tom Maniatis, Sha-Mei Liao, Gary P. Sims, Ronald Herbst and Svend T. Rietdijk. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nature Immunology, Annual Review of Immunology, Microbes and Infection and Cellular Microbiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.